Engineering a living human Mini-heart and a swimming Bio-robot

The project aims to develop advanced in vitro human cardiac models, including a vascularized mini-heart and a bio-robot, to better assess cardiotoxicity and improve understanding of cardiovascular disease.

Subsidie
€ 4.475.946
2022

Projectdetails

Introduction

Cardiovascular disease (CVD) is still the number one cause of death worldwide despite the significant efforts of academia and the pharmaceutical industry to understand the different underlying causes of CVD.

Challenges in Current Models

These efforts have been hampered by the lack of proper human cardiac models.

  1. Animal Models: Animal models have different physiology and gene expression from the human situation.
  2. In Vitro Models: Flat cell culture in vitro models are not capable of producing pumping motion, which is the main function of the heart.

Regulatory Concerns

Furthermore, pesticide toxicity and risk for human health are controlled at a European level through a well-developed regulatory network. However, cardiotoxicity is not described as a separate hazard class, even though it can have long-term cardiovascular complications.

Proposed Solution

Here we propose to create better predictive in vitro cardiac models by developing:

  • A vascularized beating mini-heart
  • A self-propulsion swimming bio-robot

These will be made by assembling human cardiac cells into 3D tissue structures using sacrificial molding and high-resolution 3D bio-printing.

Benefits of the Project

The mini-heart and the bio-robot will enable the scientific community to have:

  • A more realistic human cardiac model in vitro
  • A proper tool to assess the presence of cardiotoxicants in the environment

Consortium Collaboration

This work will be done in a consortium of four parties with the necessary expertise, including:

  • Heart development
  • Human pluripotent stem cells
  • 3D bioprinting
  • Tissue engineering
  • Biosensing

Together, we aim to bring these engineered living tissues to reality.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 4.475.946
Totale projectbegroting€ 4.475.946

Tijdlijn

Startdatum1-11-2022
Einddatum31-10-2027
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • UNIVERSITEIT TWENTEpenvoerder
  • NANOSCALE SYSTEMS, NANOSS GMBH
  • RIVER BIOMEDICS B.V.
  • UNIVERSIDAD DE MALAGA
  • METATISSUE - BIOSOLUTIONS, LDA

Land(en)

NetherlandsGermanySpainPortugal

Vergelijkbare projecten binnen EIC Pathfinder

EIC Pathfinder

High-throughput ultrasound-based volumetric 3D printing for tissue engineering

SONOCRAFT aims to revolutionize myocardial cell construct bioprinting by combining rapid volumetric printing with ultrasonic manipulation to create functional cardiac models for drug testing and disease research.

€ 2.999.625
EIC Pathfinder

building vascular networks and Blood-Brain-Barriers through a Biomimetic manufacturing Technology for the fabrication of Human tissues and ORgans

THOR aims to revolutionize tissue engineering by creating patient-specific, fully functional human tissues using bioinspired mini-robots, eliminating the need for organ transplants.

€ 3.994.150
EIC Pathfinder

Blood as energy source to power smart cardiac devices

The BLOOD2POWER project aims to develop energy-harvesting vascular grafts using triboelectric nanogenerators to monitor performance and prevent failure through wireless data transmission.

€ 2.885.525

Vergelijkbare projecten uit andere regelingen

ERC Advanced...

Advanced human models of the heart to understand cardiovascular disease

Heart2Beat aims to develop innovative 3D human cardiac models using microfluidic technology to enhance understanding and treatment of cardiovascular diseases through personalized medicine.

€ 2.500.000
ERC Starting...

Development of novel 3D vascularized cardiac models to investigate Coronary Microvascular Disease

The 3DVasCMD project aims to develop a 3D vascularized cardiac model using iPSC technology to study coronary microvascular disease and identify therapeutic targets for improved cardiovascular health.

€ 1.496.395
ERC Starting...

Computationally and experimentallY BioEngineeRing the next generation of Growing HEARTs

G-CYBERHEART aims to develop innovative experimental and computational methods for creating adaptable bioengineered hearts to improve treatment for congenital heart disease.

€ 1.497.351
EIC Transition

Bringing 3D cardiac tissues to high throughput for drug discovery screens

Developing a high-throughput 3D cardiac model using microfluidic technology to enhance drug discovery for cardiovascular disease by improving predictive accuracy and scalability.

€ 1.457.500
ERC Consolid...

3D-assembly of interactive microgels to grow in vitro vascularized, structured, and beating human cardiac tissues in high-throughput

HEARTBEAT aims to create personalized, vascularized millimeter-scale heart tissues using innovative microgel assemblies to enhance stem cell interactions and mimic native environments.

€ 2.969.219